logo

For the Inventor, By the Inventor

Esplugues de Llobregat, Spain

Laboratorios Salvat, S.a.

USPTO Granted Patents = 15

% Expired Patents = 53.3



Trademarks = 9

Forward Citations = 55

Loading Chart...
Loading Chart...

45 inventors (with patents filed for the assignee):

goldMedal Juan Lorenzo Catena Ruiz (7 out of 9 patents)

silverMedal Isabel Masip Masip (4 out of 5 patents)

bronzeMedal Carmen Lagunas Arnal (4 out of 5 patents)

4.  Carles Farrerons Gallemi (3 out of 4 patents)

5.  Carolina Salcedo Roca (3 out of 4 patents)

6.  María Isabel Delgado Gañán (3 out of 3 patents)

7.  Francisca Izquierdo Torres (2 out of 2 patents)

8.  Ester Monlleó Mas (2 out of 2 patents)

9.  María Del Carmen Serra Comas (2 out of 2 patents)

10.  Carme Serra Comas (2 out of 2 patents)

11.  Oscar Rey Puiggros (2 out of 2 patents)

12.  Albert Antolin Hernandez (2 out of 2 patents)

13.  José Hidalgo Rodriguez (2 out of 2 patents)

14.  Ignacio José Miquel Bono (2 out of 3 patents)

15.  Dolors Balsa Lopez (2 out of 3 patents)


15 patents:

1. 12246006 - Single-dose packaged clotrimazole liquid composition (2025-03-11),
2. 11672798 - Ciprofloxacin ophthalmic topical composition for treating ocular disease (2023-06-13),
3. 10857160 - Oil-in-water nanoemulsion composition of clobetasol (2020-12-08),
4. 10660848 - Ophthalmic compositions (2020-05-26),
5. 9040701 - Apaf-1 inhibitor compounds (2015-05-26),
6. 8932610 - Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation (2015-01-13),
7. 8871787 - [object Object] (2014-10-28),
8. 8822452 - Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 (2014-09-02),
9. 8524894 - Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 (2013-09-03),
10. 8492402 - [object Object] (2013-07-23),
11. 7423172 - Tyrosine derivatives as PPAR-γ-modulators (2008-09-09),
12. 7115629 - Carbamates derived from arylalkylamines (2006-10-03),
13. 6916828 - Carbamates derivatived from arylakylamines (2005-07-12),
14. 6670365 - Substituted imidazo 1,2a}azines as selective inhibitors of cox-2 (2003-12-30),
15. 5798348 - Fatty-acid monoesters of estrogens for the treatment of obesity and/or (1998-08-25),
Company Overview
Laboratorios Salvat, S.A. is a pharmaceutical company based in Esplugues de Llobregat, Spain, specializing in the development and manufacturing of innovative healthcare products. The organization focuses on various therapeutic areas, including dermatology, oncology, and infectious diseases, emphasizing the importance of research and development in creating effective treatments. With a commitment to quality and patient care, Laboratorios Salvat aims to address unmet medical needs through its diverse portfolio of pharmaceutical solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

15 Patents

#1 in Esplugues de Llobregat

#142 in Spain

#39,959 in the World

Esplugues de Llobregat, ES
Esplugues de Llobregat, Spain

Laboratorios Salvat, S.a.

Forward Citations = 55

45 inventors:

goldMedal Juan Lorenzo Catena Ruiz (7 out of 9 patents)

silverMedal Isabel Masip Masip (4 out of 5 patents)

bronzeMedal Carmen Lagunas Arnal (4 out of 5 patents)

4.  Carles Farrerons Gallemi (3 out of 4 patents)

5.  Carolina Salcedo Roca (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Laboratorios Salvat, S.a.. Retrieved from https://idiyas.com/company/laboratorios-salvat-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…